Through Named Patient Programs in specific markets, LYMPHIR gives eligible patients outside the U.S. access where approved alternatives may be limited.Read More
First LYMPHIR cancer-drug shipment reaches Europe via named-patient access
By Stock Titan
MGSN.net
